Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
Appointed director
CC transcript
Upcoming conference date
Auditor change
Appointed CFO
PONIARD PHARMACEUTICALS, INC. (PARD) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/02/2011 8-K Form 8-K - Current report
08/16/2011 8-K Form 8-K - Current report
03/30/2011 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results"
11/09/2010 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Third Quarter 2010 Financial Results"
05/10/2010 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports First Quarter 2010 Financial Results - Conference Call Today at 4:30 p.m. Eastern Time -"
11/03/2009 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update"
05/05/2009 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update"
03/16/2009 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update",
"Poniard Pharmaceuticals Receives Going Concern Qualification"
11/03/2008 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update"
08/04/2008 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update"
05/08/2008 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update",
"Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer"
11/02/2007 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Third Quarter 2007 Financial Results and Corporate Update",
"Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer"
08/08/2007 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports Second Quarter 2007 Financial Results and Corporate Update"
05/14/2007 8-K Quarterly results
Docs: "Poniard Pharmaceuticals Reports First Quarter 2007 Financial Results"
05/18/2006 8-K Quarterly results
Docs: "NeoRx Corporation Reports First Quarter Financial Results"
11/10/2005 8-K Quarterly results
Docs: "NeoRx Reports Third Quarter 2005 Financial Results"
08/10/2005 8-K Quarterly results
Docs: "The Scripps Research Institute Keith McKeown [email protected] 784-8134",
"NeoRx Reports Second Quarter 2005 Financial Results"
05/12/2005 8-K Quarterly results
Docs: "NeoRx Reports First Quarter Financial Results"
03/18/2005 8-K Quarterly results
Docs: "NeoRx Reports Fourth Quarter and Full Year Financial Results and Corporate Highlights Management to Hold Conference Call Today at 4:30 p.m. ET",
"Amended and Restated Articles of Incorporation"
11/08/2004 8-K Quarterly results
Docs: "NEORX REPORTS THIRD QUARTER 2004 FINANCIAL RESULTS Management to Hold Conference Call at 4:30 p.m. ET Today"
08/04/2004 8-K Quarterly results
Docs: "NEORX REPORTS SECOND QUARTER 2004 FINANCIAL RESULTS Management to Hold Conference Call at 12:00 p.m. ET Today"
04/26/2004 8-K Quarterly results
Docs: "NEORX REPORTS FIRST QUARTER 2004 RESULTS"
02/23/2004 8-K Quarterly results
Docs: "NEORX REPORTS FOURTH QUARTER AND FULL YEAR 2003 RESULTS"
11/14/2003 8-K Quarterly results
Docs: "NEORX ANNOUNCES ALLOWANCE OF ADDITIONAL PATENT CLAIMS TO STR FOR CANCER THERAPY",
"NEORX REPORTS THIRD QUARTER 2003 RESULTS"
08/01/2003 8-K Quarterly results
Docs: "NEORX REPORTS SECOND QUARTER 2003 RESULTS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy